Exciting to see our paper in @TheLancetNeuro on the world’s largest study of age at symptom onset/death and disease duration in genetic frontotemporal dementia.
Privileged to have led the study as part of the FTD Prevention Initiative and @GENFI1. #endftd https://t.co/kM7TLfpFJj
Those Camels and Cacti ! Now detecting semantic impairment even presymptomatically in those carrying mutations associated with FTD - MAPT, GRN, C9orf72. Nice paper from Katrina Moore @GENFI1#SemanticDementia#FrontotemporalDementia@jonrohrer
Work from our team led by Carolin Heller @UkdriL now out in JNNP - data from @GENFI1 study shows raised GFAP in blood in progranulin mutation carriers in FTD. Will be useful marker in forthcoming trials. #endftd
The first paper of my PhD is out: https://t.co/FWY0aWl1Kn. Higher CSF synaptic protein concentrations of (certain fragments of) neurogranin, SNAP-25, and synaptotagmin-1 appear to be related to AD pathology. The search for synaptic biomarkers of FTD continues... @FTDtalk#endftd
24 hours into being Dr Katrina Moore PhD 🤓So incredibly proud to have achieved this alongside these truly brilliant inspirational people 🥂 to top it all off according to my US visa I’m officially a person of extraordinary ability 🇺🇸 #endftd#WomenInScience
Congratulations to our new Dr in the team @KatrinaDick who passed her PhD viva today! We are all very proud of her and the great work she has done in genetic FTD #endftd
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Age at onset and at death is influenced by genetic group and by the specific mutation carried and by family membership. https://t.co/8GiuMfpU1Y
PhD researcher @marthafoiani@UCLIoN explains how a simple blood test could help detect signs of Alzheimer’s disease far earlier, and far more easily, than current methods in a segment with Prof @Kevin_Fong@UCLSTEAPP for @BBCTheOneShow
Who said PhD studentships were just about training?
@alzheimerssoc funded student Katrina Moore delivers major progress about FTD age of onset published in @TheLancetNeuro 👏🏻
Genetic frontotemporal dementia - the major new global overview by Katrina Moore for the FTD Prevention Initiative. Can you predict age of onset? What modifies the genetic phenotype? Are preventive trials realistic? see https://t.co/VM9Jgj8rXh
@GENFI1@jonrohrer@TheLancetNeuro
The 1st paper is out in @TheLancetNeuro from the FTD Prevention Initiative (FPI), joining @GENFI1 & ALLFTD studies. We have spent the last few years collecting data from across the world leading to the largest study in genetic FTD so far. @KatrinaDick https://t.co/MJOmY9jRs1
Very excited to see @KatrinaDick’s @TheLancetNeuro@GENFI1 paper out in the world - a huge study reporting age at symptom onset and death of people with genetic FTD is influenced by genetic group/mutation, particularly for MAPT #endftd
This week is FTD awareness week - the GENFI study has now reached 1000 participants and is dedicated to working towards a cure for frontotemporal dementia @ftdtalk @jonrohrer #endftd